| ABBOTT LABORATORIES www.abbott.com | | Industry Group Code: 325412 | | | | Ranks within this company's industry group: | | Sales: 8 | Profits:9 |
| | | Insurance/HMO/PPO: | | Insurance: | | | Managed Care: | | | Utilization Management: | | | Payment Processing: | | | | | | | |
| | Drugs: | | Manufacturer: | Y | | Distributor: | | | Specialty Pharmacy: | | | Vitamins/Nutritionists: | Y | | Clinical Trials: | | | | |
| | Equipment/Supplies: | | Manufacturer: | Y | | Distributor: | | | Leasing/Finance: | | | Information Systems: | | | | | |
| | Hospitals/Clinics: | | Acute Care: | | | Sub-Acute: | | | Outpatient Surgery: | | | Physical Rehab. Ctr.: | | | Psychiatric Clinics: | | | |
| | Services: | | Diagnostics: | | | Labs/Testing: | | | Staffing: | | | Waste Disposal: | | | Specialty Services: | | | | |
| | Health Care: | | Home Health: | | | Long-Term Care: | | | Physical Therapy: | | | Physician Prac. Mgmt.: | | | | | |
|
| TYPES OF BUSINESS: | BRANDS/DIVISIONS/AFFILIATES | Pharmaceuticals Manufacturing
Nutritional Products
Diagnostics
Consumer Health Products
Medical & Surgical Devices
Pharmaceutical Products
Animal Health
|
| Vysis Inc
I-Stat Corp
KOS Pharmaceuticals Inc
Experimental & Applied Sciences Inc
Humira
Simcor
Similac
Ensure
| | CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. | Miles D. White, CEO
Richard A. Gonzalez, COO
Thomas C. Freyman, CFO
Stephen R. Fussell, Sr. VP-Human Resources
John C. Landgraf, Sr. VP-Global Pharmaceutical Mgmt. & Supply
Laura J. Schumacher, General Counsel/Exec. VP/Corp. Sec.
Richard Ashley, Exec. VP-Corp. Dev.
Melissa Brotz, VP-External Comm.
Thomas C. Freyman, Exec. VP-Finance
William G. Dempsey, Exec. VP-Pharmaceutical Group
Holger Liepmann, Exec. VP-Global Nutrition
John M. Capek, Exec. VP-Medical Devices
Edward L. Michael, Exec. VP-Diagnostics
Miles D. White, Chmn.
Olivier Bohuon, Sr. VP-Int'l Oper.
| | Phone: 847-937-6100 | | Fax: 847-937-9555 | | Toll-Free: N/A | Address: 100 Abbott Park Rd.
Abbott Park, IL 60064, US |
| | GROWTH PLANS/SPECIAL FEATURES | Abbott Laboratories' principal business is to discover, develop, manufacture and sell health care products and technologies ranging from pharmaceuticals, animal health products and medical devices. The pharmaceutical segment deals with adult and pediatric conditions such as rheumatoid arthritis, HIV, epilepsy and manic depression. The diagnostic instruments and test segment deals with a range of medical tests to diagnose infectious diseases, cancer, diabetes and genetic conditions. The nutritional products segment offers consumer products such as Similac, Ensure, Glucerna and AdvantEdge, as well as medical nutritional products and feeding devices. The medical and surgical devices segment includes minimally invasive treatment options that improve the care of people with vascular disease and spinal conditions. Vascular offerings include vessel closure devices, carotid and coronary stents, catheters and other interventional tools and devices. This segment also produces minimally invasive spinal fixation products. The animal health segment serves the veterinarian market with products that include anesthetic and wound care products, nutritional supplements, and intravenous sets and solutions. The company operates internationally in Europe, Asia, Africa, Latin and South America and the Middle East. Abbott’s holds a 50% share in TAP Pharmaceutical Products, which makes the prostate cancer drug, Lupron, and Prevacid (Ogastro), a proton pump inhibitor for the short-term treatment of gastroesophageal reflux disease. In 2008, the firm received FDA approval for Humira, a medication for polyarticular juvenile idiopathic arthritis, as well as Simcor, a combination medicine for comprehensive cholesterol management.
Employee benefits include medical, dental and vision coverage; flexible spending accounts; profit sharing; 401(k); retirement pension; employee assistance program; tuition assistance; paternity leave; and life and AD&D insurance. |
| FINANCIALS: Sales and profits are in thousands of dollars-add 000 to get the full amount. Yr. 2007 note: Fiscal 2007 results were not available for all companies at press time. For this company, yr. 2007 is for months. | | 2007 Sales: | $25,914,200 | ( months) | 2007 Profits: | $3,606,300 | ( months) | | 2006 Sales: | $22,476,322 | | 2006 Profits: | $1,716,255 | | | 2005 Sales: | $22,337,808 | | 2005 Profits: | $3,372,065 | | | 2004 Sales: | $19,680,016 | | 2004 Profits: | $3,235,851 | | | 2003 Sales: | $19,680,600 | | 2003 Profits: | $2,753,200 | | Stock Ticker: ABT | Employees: 68,000 | Fiscal Year Ends: 12/31 |
| SALARIES/BENEFITS: | | Pension Plan: Y | ESOP Stock Plan: | Profit Sharing: Y | | Savings Plan: Y | Stock Purch. Plan: | | | | | | Top Exec. Salary: $1,661,973 | Bonus: $1,535,000 | | Second Exec. Salary: $973,931 | Bonus: $1,535,000 |
| OTHER THOUGHTS: | LOCATIONS: ('Y' = YES) | | Apparent Top Female Officers: 11 | W | SW | MW | SE | NE | INTER. | | Hot Spots for Advancement for Women/Minorities: Y | Y | Y | Y |
| Y | Y |
|